The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Biochemical mechanisms of drug action: what does it take for success?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle
Fleckenstein, A. (1977) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.17.040177.001053 · Cited by 1,713
Lewis, H. D., Davis, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Pouget, J. M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090703 · Cited by 1,709
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
Roth, G. J., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108132 · Cited by 861
Lee, K. S., & Tsien, R. W. (1983) · Nature · doi:10.1038/302790a0 · Cited by 842
A Kinetic Basis For T Cell Receptor Repertoire Selection during an Immune Response
Savage, P. A., Boniface, J. J., & Davis, M. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80048-5 · Cited by 497
5-lipoxygenase inhibitory activity of zileuton.
Carter, G. W., Young, P. R., Albert, D. H., Bouska, J., Dyer, R., Bell, R. L., Summers, J. B., & Brooks, D. W. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23086-5 · Cited by 420
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
Copeland, R. A., Williams, J. M., Giannaras, J., Nurnberg, S., Covington, M., Pinto, D., Pick, S., & Trzaskos, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11202 · Cited by 408
The Pharmacology of the Gastric Acid Pump: The H+,K+ ATPase
Sachs, G., Shin, J. M., Briving, C., Wallmark, B., & Hersey, S. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001425 · Cited by 367
Bar-On, P., Millard, C. B., Harel, M., Dvir, H., Enz, A., Sussman, J. L., & Silman, I. (2002) · Biochemistry · doi:10.1021/bi020016x · Cited by 328
Kinetic discrimination in T-cell activation.
Rabinowitz, J. D., Beeson, C., Lyons, D. S., Davis, M. M., & McConnell, H. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1401 · Cited by 299
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Pharmacology of competitive inhibitors of HMg-CoA reductase
Corsini, A. (1995) · Pharmacological Research · doi:10.1016/1043-6618(95)80042-5 · Cited by 277
Criscione, L., de Gasparo, M., Bühlmayer, P., Whitebread, S., Ramjoué, H. R., & Wood, J. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13877.x · Cited by 250
Kemppainen, J. A. (1999) · Molecular Endocrinology · doi:10.1210/me.13.3.440 · Cited by 207
Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.
Kuo, C. C., & Bean, B. P. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09804-9 · Cited by 205
Binding of Ligands and Activation of Transcription by Nuclear Receptors
Steinmetz, A. C. U., Renaud, J.-P., & Moras, D. (2001) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.30.1.329 · Cited by 205
Wienen, W., Hauel, N., Van Meel, J. C. A., Narr, B., Ries, U., & Entzeroth, M. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13800.x · Cited by 191
Nilvebrant, L., Hallén, B., & Larsson, G. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00057-x · Cited by 187
Riendeau, D., Charleson, S., Cromlish, W., Mancini, J. A., Wong, E., & Guay, J. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-9-1088 · Cited by 186
Antagonism in the humanmineralocorticoid receptor
Fagart, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3317 · Cited by 169
Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
Catterall, W. A. (1999) · PubMed · Cited by 167
Bull, H. G., Garcia-Calvo, M. M., Andersson, S., Baginsky, W. F., Chan, H. K., Ellsworth, D. E., Miller, R. R., Stearns, R. A., Bakshi, R. K., Rasmusson, G. H., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja953069t · Cited by 161
The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist
Krell, R. D., Aharony, D., Buckner, C. K., Keith, R. A., Kusner, E. J., Snyder, D. W., Bernstein, P. R., Matassa, V. G., Yee, Y. K., Brown, F. J., et al. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.978 · Cited by 156
Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens
Miller, C. P., Collini, M. D., Tran, B. D., Harris, H. A., Kharode, Y. P., Marzolf, J. T., Moran, R. A., Henderson, R. A., Bender, R. H. W., Unwalla, R. J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010086m · Cited by 137
Wallmark, B., Brändström, A., & Larsson, H. (1984) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(84)90406-1 · Cited by 136
Anthes, J. C., Gilchrest, H., Richard, C., Eckel, S. P., Hesk, D., West, R. E., Williams, S. M., Greenfeder, S. A., Billah, M. M., Kreutner, W., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02049-6 · Cited by 121
Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo
Liu, X., & Bosselut, R. (2004) · Nature Immunology · doi:10.1038/ni1040 · Cited by 119
Brown, R. P. A., Aplin, R. T., & Schofield, C. J. (1996) · Biochemistry · doi:10.1021/bi961044g · Cited by 111
Novel Mechanisms of Action of Three Antiepileptic Drugs, Vigabatrin, Tiagabine, and Topiramate
Ängehagen, M., Ben‐Menachem, E., Rönnbäck, L., & Hansson, E. (2003) · Neurochemical Research · doi:10.1023/a:1022393604014 · Cited by 94
Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
van Noord, J. A., Smeets, J. J., Custers, F. L. J., Korducki, L., & Cornelissen, P. J. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00238002 · Cited by 92
The Dynamics of Prostaglandin H Synthases
So, O., Scarafia, L. E., Mak, A. Y., Callan, O., & Swinney, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5801 · Cited by 91
Self-citationKinetic stability as a mechanism for protease longevity
Cunningham, E. L., Jaswal, S. S., Sohl, J. L., & Agard, D. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11008 · Cited by 87
Progesterone receptor and the mechanism of action of progesterone antagonists
Edwards, D. P., Altmann, M., Marzo, A. M. D., Zhang, Y., Weigel, N. L., & Beck, C. A. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00091-d · Cited by 85
Newer and Older Monoamine Oxidase Inhibitors: A Comparative Profile
Laux, G., Volz, H., & Möller, H. (1995) · CNS Drugs · doi:10.2165/00023210-199503020-00006 · Cited by 69
Characterization of Celecoxib and Valdecoxib Binding to Cyclooxygenase
Hood, W. F., Gierse, J. K., Isakson, P. C., Kiefer, J. R., Kurumbail, R. G., Seibert, K., & Monahan, J. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.870 · Cited by 63
Importance of the regulation of nuclear receptor degradation
Andrew, P. (2001) · Frontiers in bioscience · doi:10.2741/dennis · Cited by 61
Waller, A. S., SHARRARD, R. M., Berthon, P., & Maitland, N. J. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240339 · Cited by 58
Johnson, B. D., Hockerman, G. H., Scheuer, T., & Catterall, W. A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09574-4 · Cited by 53
Aromatase inhibitors and the treatment of breast cancer
Brodie, A. M., Wing, L.-Y., Goss, P. E., Dowsett, M., & Coombes, R. C. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90037-3 · Cited by 48
Aldosterone antagonists destabilize the mineralocorticosteroid receptor
Couette, B., Lombès, M., Baulieu, E. E., & Rafestin-Oblin, M. E. (1992) · Biochemical Journal · doi:10.1042/bj2820697 · Cited by 46
Cell-Specific, Promoter-Dependent Mineralocorticoid Agonist Activity of Spironolactone
Massaad, C., Lombès, M., Aggerbeck, Μ., Rafestin-Oblin, M. E., & Barouki, R. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.285 · Cited by 38
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Self-citationDrug-target residence time and its implications for lead optimization
Copeland, R. A., Pompliano, D. L., & Meek, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2082 · Cited by 1,464
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
The drug–target residence time model: a 10-year retrospective
Copeland, R. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.18 · Cited by 722
Metadata
- Authors
- Swinney, D. C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-09
- Volume
- 3
- Issue
- 9
- Pages
- 801-808
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1587498640
- Cited by
- 394
- References
- 44
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.